These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 33774347)

  • 1. Occurrence of carbamazepine, diclofenac, and their related metabolites and transformation products in a French aquatic environment and preliminary risk assessment.
    Zind H; Mondamert L; Remaury QB; Cleon A; Leitner NKV; Labanowski J
    Water Res; 2021 May; 196():117052. PubMed ID: 33774347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence, ecological risk assessment and prioritization of pharmaceuticals and abuse drugs in estuarine waters along the São Paulo coast, Brazil.
    Roveri V; Guimarães LL; Toma W; Correia AT
    Environ Sci Pollut Res Int; 2022 Dec; 29(59):89712-89726. PubMed ID: 35857165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
    Maskaoui K; Zhou JL
    Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
    Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
    Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POCIS passive samplers as a monitoring tool for pharmaceutical residues and their transformation products in marine environment.
    Martínez Bueno MJ; Herrera S; Munaron D; Boillot C; Fenet H; Chiron S; Gómez E
    Environ Sci Pollut Res Int; 2016 Mar; 23(6):5019-29. PubMed ID: 25382501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking down pharmaceutical pollution in surface waters of the St. Lawrence River and its major tributaries.
    Vaudreuil MA; Munoz G; Vo Duy S; Sauvé S
    Sci Total Environ; 2024 Feb; 912():168680. PubMed ID: 37996029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment.
    Langford K; Thomas KV
    J Environ Monit; 2011 Feb; 13(2):416-21. PubMed ID: 21152649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic exposure to a pharmaceutical mixture on the three-spined stickleback (gasterosteus aculeatus) population dynamics in lotic mesocosms.
    David V; Joachim S; Catteau A; Nott K; Ronkart S; Robert C; Gillard N; Bado-Nilles A; Chadili E; Palluel O; Turies C; Julian N; Castiglione J; Dedourge-Geffard O; Hani Y; Geffard A; Porcher JM; Beaudouin R
    Aquat Toxicol; 2020 Jul; 224():105499. PubMed ID: 32416570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).
    Duarte DJ; Niebaum G; Lämmchen V; van Heijnsbergen E; Oldenkamp R; Hernández-Leal L; Schmitt H; Ragas AMJ; Klasmeier J
    Environ Toxicol Chem; 2022 Mar; 41(3):648-662. PubMed ID: 33818825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence, bioaccumulation and risk assessment of lipophilic pharmaceutically active compounds in the downstream rivers of sewage treatment plants.
    Liu J; Lu G; Xie Z; Zhang Z; Li S; Yan Z
    Sci Total Environ; 2015 Apr; 511():54-62. PubMed ID: 25531589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
    Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
    Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters.
    Tixier C; Singer HP; Oellers S; Müller SR
    Environ Sci Technol; 2003 Mar; 37(6):1061-8. PubMed ID: 12680655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom.
    Ashton D; Hilton M; Thomas KV
    Sci Total Environ; 2004 Oct; 333(1-3):167-84. PubMed ID: 15364527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration and risk of pharmaceuticals in freshwater systems are related to the population density and the livestock units in Iberian Rivers.
    Osorio V; Larrañaga A; Aceña J; Pérez S; Barceló D
    Sci Total Environ; 2016 Jan; 540():267-77. PubMed ID: 26170112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and risk assessment of pharmaceuticals in surface waters of the Middle East and North Africa: A review.
    Mheidli N; Malli A; Mansour F; Al-Hindi M
    Sci Total Environ; 2022 Dec; 851(Pt 2):158302. PubMed ID: 36030863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.
    Zhao JL; Ying GG; Liu YS; Chen F; Yang JF; Wang L; Yang XB; Stauber JL; Warne MS
    Environ Toxicol Chem; 2010 Jun; 29(6):1377-84. PubMed ID: 20821582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk screening of pharmaceutical compounds in Romanian aquatic environment.
    Gheorghe S; Petre J; Lucaciu I; Stoica C; Nita-Lazar M
    Environ Monit Assess; 2016 Jun; 188(6):379. PubMed ID: 27234514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected Pharmaceuticals in Different Aquatic Compartments: Part II-Toxicity and Environmental Risk Assessment.
    Pereira A; Silva L; Laranjeiro C; Lino C; Pena A
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro river basin (NE Spain).
    López-Serna R; Petrović M; Barceló D
    Sci Total Environ; 2012 Dec; 440():280-9. PubMed ID: 22809787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.